146 related articles for article (PubMed ID: 16982954)
1. Insulin resistance and obesity in a mouse model of systemic lupus erythematosus.
Ryan MJ; McLemore GR; Hendrix ST
Hypertension; 2006 Nov; 48(5):988-93. PubMed ID: 16982954
[TBL] [Abstract][Full Text] [Related]
2. Insulin resistance and obesity in a mouse model of systemic lupus erythematosus.
Perciaccante A; Fiorentini A; Tubani L
Hypertension; 2007 Feb; 49(2):e12; author reply e13. PubMed ID: 17159078
[No Abstract] [Full Text] [Related]
3. Endothelin receptor antagonism improves glucose tolerance and adipose tissue inflammation in an experimental model of systemic lupus erythematosus.
Rivera-Gonzalez O; Case CT; Wilson NA; Speed JS; Taylor EB
Am J Physiol Endocrinol Metab; 2023 Jan; 324(1):E73-E84. PubMed ID: 36476039
[TBL] [Abstract][Full Text] [Related]
4. Blood pressure and renal hemodynamic responses to acute angiotensin II infusion are enhanced in a female mouse model of systemic lupus erythematosus.
Venegas-Pont M; Mathis KW; Iliescu R; Ray WH; Glover PH; Ryan MJ
Am J Physiol Regul Integr Comp Physiol; 2011 Nov; 301(5):R1286-92. PubMed ID: 21900645
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppression With Mycophenolate Mofetil Attenuates Hypertension in an Experimental Model of Autoimmune Disease.
Taylor EB; Ryan MJ
J Am Heart Assoc; 2017 Feb; 6(3):. PubMed ID: 28242635
[TBL] [Abstract][Full Text] [Related]
6. Impact of early life ovariectomy on blood pressure and body composition in a female mouse model of systemic lupus erythematosus.
Gilbert EL; Ryan MJ
Am J Physiol Regul Integr Comp Physiol; 2014 Oct; 307(8):R990-7. PubMed ID: 25324553
[TBL] [Abstract][Full Text] [Related]
7. Hypertension in an experimental model of systemic lupus erythematosus occurs independently of the renal nerves.
Mathis KW; Venegas-Pont M; Flynn ER; Williams JM; Maric-Bilkan C; Dwyer TM; Ryan MJ
Am J Physiol Regul Integr Comp Physiol; 2013 Oct; 305(7):R711-9. PubMed ID: 23926131
[TBL] [Abstract][Full Text] [Related]
8. Temporal hemodynamic changes in a female mouse model of systemic lupus erythematosus.
Dent EL; Taylor EB; Sasser JM; Ryan MJ
Am J Physiol Renal Physiol; 2020 May; 318(5):F1074-F1085. PubMed ID: 32150445
[TBL] [Abstract][Full Text] [Related]
9. Altered levels of adipocytokines in association with insulin resistance in patients with systemic lupus erythematosus.
Sada KE; Yamasaki Y; Maruyama M; Sugiyama H; Yamamura M; Maeshima Y; Makino H
J Rheumatol; 2006 Aug; 33(8):1545-52. PubMed ID: 16881111
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune-mediated glucose intolerance in a mouse model of systemic lupus erythematosus.
Gabriel CL; Smith PB; Mendez-Fernandez YV; Wilhelm AJ; Ye AM; Major AS
Am J Physiol Endocrinol Metab; 2012 Dec; 303(11):E1313-24. PubMed ID: 23032686
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor-alpha antagonist etanercept decreases blood pressure and protects the kidney in a mouse model of systemic lupus erythematosus.
Venegas-Pont M; Manigrasso MB; Grifoni SC; LaMarca BB; Maric C; Racusen LC; Glover PH; Jones AV; Drummond HA; Ryan MJ
Hypertension; 2010 Oct; 56(4):643-9. PubMed ID: 20696988
[TBL] [Abstract][Full Text] [Related]
12. 17β-Estradiol protects against the progression of hypertension during adulthood in a mouse model of systemic lupus erythematosus.
Gilbert EL; Mathis KW; Ryan MJ
Hypertension; 2014 Mar; 63(3):616-23. PubMed ID: 24366082
[TBL] [Abstract][Full Text] [Related]
13. Plasma Cell Depletion Attenuates Hypertension in an Experimental Model of Autoimmune Disease.
Taylor EB; Barati MT; Powell DW; Turbeville HR; Ryan MJ
Hypertension; 2018 Apr; 71(4):719-728. PubMed ID: 29378858
[TBL] [Abstract][Full Text] [Related]
14. Human recombinant relaxin-2 does not attenuate hypertension or renal injury but exacerbates vascular dysfunction in a female mouse model of SLE.
Wolf VL; Phillips TL; Taylor EB; Sasser JM; Ryan MJ
Am J Physiol Heart Circ Physiol; 2019 Aug; 317(2):H234-H242. PubMed ID: 31125285
[TBL] [Abstract][Full Text] [Related]
15. Hypertension and impaired vascular function in a female mouse model of systemic lupus erythematosus.
Ryan MJ; McLemore GR
Am J Physiol Regul Integr Comp Physiol; 2007 Feb; 292(2):R736-42. PubMed ID: 16971374
[TBL] [Abstract][Full Text] [Related]
16. Blood pressure in a hypertensive mouse model of SLE is not salt-sensitive.
Mathis KW; Venegas-Pont M; Masterson CW; Wasson KL; Ryan MJ
Am J Physiol Regul Integr Comp Physiol; 2011 Nov; 301(5):R1281-5. PubMed ID: 21917908
[TBL] [Abstract][Full Text] [Related]
17. Metabolic syndrome is associated with increased arterial stiffness and biomarkers of subclinical atherosclerosis in patients with systemic lupus erythematosus.
Sabio JM; Vargas-Hitos J; Zamora-Pasadas M; Mediavilla JD; Navarrete N; Ramirez A; Hidalgo-Tenorio C; Jáimez L; Martín J; Jiménez-Alonso J;
J Rheumatol; 2009 Oct; 36(10):2204-11. PubMed ID: 19723903
[TBL] [Abstract][Full Text] [Related]
18. Cholinergic agonists reduce blood pressure in a mouse model of systemic lupus erythematosus.
Fairley AS; Mathis KW
Physiol Rep; 2017 Apr; 5(7):. PubMed ID: 28400502
[TBL] [Abstract][Full Text] [Related]
19. Oxidative stress promotes hypertension and albuminuria during the autoimmune disease systemic lupus erythematosus.
Mathis KW; Venegas-Pont M; Masterson CW; Stewart NJ; Wasson KL; Ryan MJ
Hypertension; 2012 Mar; 59(3):673-9. PubMed ID: 22291449
[TBL] [Abstract][Full Text] [Related]
20. Rosiglitazone decreases blood pressure and renal injury in a female mouse model of systemic lupus erythematosus.
Venegas-Pont M; Sartori-Valinotti JC; Maric C; Racusen LC; Glover PH; McLemore GR; Jones AV; Reckelhoff JF; Ryan MJ
Am J Physiol Regul Integr Comp Physiol; 2009 Apr; 296(4):R1282-9. PubMed ID: 19193937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
